Completed
A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
NCT03981146
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- Queen Elizabeth Hospital Birmingham, United Kingdom
- Velindre Cancer Centre Cardiff, United Kingdom
- Western General Hospital Edinburgh, United Kingdom